Skip to main content

MoneyWorks4Me

The sales is pegged at Rs. 390.60 millions for the March 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 413.98 millions during the year-ago period.A slender decline of -9.89% was recorded to Rs. 13.12  millions from Rs. 14.56 millions in the corresponding previous quarter.Operating Profit saw a handsome growth to 41.38 millions from 34.03 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 390.60 413.98 -5.65 1458.57 1524.66 -4.33 1458.57 1524.66 -4.33
Other Income 10.25 5.15 99.03 27.42 35.22 -22.15 27.42 35.22 -22.15
PBIDT 41.38 34.03 21.60 139.19 146.34 -4.89 139.19 146.34 -4.89
Interest 8.22 6.76 21.60 27.31 22.90 19.26 27.31 22.90 19.26
PBDT 15.27 27.27 -44.00 90.42 123.44 -26.75 90.42 123.44 -26.75
Depreciation 2.15 12.71 -83.08 48.90 49.95 -2.10 48.90 49.95 -2.10
PBT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 10.59 8.22 28.88 9.54 9.60 -0.58 9.54 9.60 -0.58
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..